 Connection
Michael Rizzari to Hepatitis C
This is a "connection" page, showing publications Michael Rizzari has written about Hepatitis C.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.304 |
|
|
|
-
Shimada S, Ivanics T, Kitajima T, Shamaa T, Rizzari M, Collins K, Yoshida A, Abouljoud M, Moonka D, Zhang J, Lu M, Nagai S. Improvements in liver transplant outcomes in patients with HCV/HIV coinfection after the introduction of direct-acting antiviral therapies. Transpl Infect Dis. 2022 Apr; 24(2):e13808.
Score: 0.145
-
Ivanics T, Rizzari M, Moonka D, Al-Kurd A, Delvecchio K, Kitajima T, Elsabbagh AM, Collins K, Yoshida A, Abouljoud M, Nagai S. Retransplantation outcomes for hepatitis C in the United States before and after direct-acting antiviral introduction. Am J Transplant. 2021 03; 21(3):1100-1112.
Score: 0.131
-
Nagai S, Chau LC, Schilke RE, Safwan M, Rizzari M, Collins K, Yoshida A, Abouljoud MS, Moonka D. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes. Gastroenterology. 2018 11; 155(5):1451-1462.e3.
Score: 0.028
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|